Stereotactic laser ablation for subependymal giant cell astrocytomas: personal experience and review of the literature

Stereotactic laser ablation for subependymal giant cell astrocytomas: personal experience and review of the literature

Purpose Subependymal giant cell astrocytomas (SEGAs) are rare tumors typically found in tuberous sclerosis patients. They typically grow in the region of the foramen of Monro and can occlude it, leading to hydrocephalus. Currently, gross total resection is the standard of care, with low rates of rec...

Full description

Saved in:
Bibliographic Details
Published in:Child's nervous system Vol. 36; no. 11; pp. 2685 - 2691
Main Authors: Desai, Virendra R., Jenson, Amanda V., Hoverson, Eric, Desai, Rajendra M., Boghani, Zain, Lee, Mark R.
Format: Journal Article
Language:English
Published: Berlin/Heidelberg Springer Berlin Heidelberg 01-11-2020
Subjects:
Medicine
Medicine & Public Health
Neurosciences
Neurosurgery
Original Article
Subependymal giant cell astrocytoma
Laser ablation
Septostomy
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose Subependymal giant cell astrocytomas (SEGAs) are rare tumors typically found in tuberous sclerosis patients. They typically grow in the region of the foramen of Monro and can occlude it, leading to hydrocephalus. Currently, gross total resection is the standard of care, with low rates of recurrence but high rates of complication, especially with larger lesions. Laser interstitial thermal therapy (LITT) is a newly emerging treatment modality for a variety of pathologies. Here, we present a case series of SEGAs managed via LITT and endoscopic, stereotactic septostomy. Methods A retrospective chart review was performed to identify three cases in which SEGAs were treated via LITT and septostomy. Stereotactic ablation was performed via magnetic resonance (MR) thermometry with laser output set to 69% for 2.5 min, with post-ablation scans for visualization of treatment area. Results Average age at surgery was 8.2 years. Pre-operative tumor volumes were 0.43, 1.51, and 3.88 cm 3 . Post-operative tumor volumes were 0.25, 0.21, and 0.68 cm 3 . Mean tumor volume reduction was 70%. No complications occurred. Conclusion LITT with septostomy should be considered a viable primary or adjunct treatment modality for SEGAs.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0256-7040
1433-0350
DOI:10.1007/s00381-020-04638-y